Industry News
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Bimatoprost ophthalmic solution 0.01% launch by Amneal Pharmaceuticals expands access to affordable glaucoma and ...
APRIL 10, 2026
Pestle Introduces New IVWMS for Compounding
Pestle announced the launch of a new IV workflow management system for compounding.
MARCH 12, 2026
Long Grove Pharmaceuticals Launches Generic Dalbavancin for Injection
Long Grove Pharmaceuticals received FDA approval for the generic version of dalbavancin for injection.
MARCH 12, 2026
Skincare Products Recalled Because of B. cepacia Contamination
The FDA announced a recall of individual lots of products made by DermaRite Industries due to microbial ...
AUGUST 11, 2025
Long Grove Pharmaceuticals Introduces Generic Methadone Hydrochloride Injection, USP
New methadone injection supports safe, consistent treatment of pain and opioid dependence in critical care and ...
JULY 28, 2025
Camber Pharmaceuticals Announces Availability of Chlorpromazine HCl Injection, USP
Camber Pharmaceuticals announces the addition of Chlorpromazine HCl Injection, USP to its current portfolio.
JUNE 20, 2025
Prefilled Ketamine Syringes Coming Soon
Leiters Health announced that it is now producing prefilled ketamine syringes from commercially available finished ...
JUNE 18, 2025
Sanofi Accelerates Beyfortus Shipping Ahead of Next RSV Season
Sanofi said it would ship nirsevimab starting earlier to ensure broad availability well ahead of the 2025-2026 RSV ...
JUNE 9, 2025
A.forall Announces First U.S. Launch of Tromethamine Injection 18 g/500 mL
A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New ...
MAY 30, 2025
Meitheal Pharmaceuticals Launches Generic Paclitaxel
Meitheal Pharmaceuticals Inc. announced it has launched, through an exclusive license and supply agreement with its ...
MAY 30, 2025
Amneal Launches GLP-1 Agonist Exenatide Injection
Amneal Pharmaceuticals has launched exenatide 1.2 and 2.4 mL prefilled pen injection, an AP-rated generic ...
MAY 29, 2025
Amneal Launches Boruzu for Multiple Myeloma and Mantle Cell Lymphoma
Amneal Pharmaceuticals Inc. and Shilpa Medicare Limited announced the U.S. launch of Boruzu, a new presentation of ...
APRIL 4, 2025
